SLC9C1 and myocardial infarction: Previous investigations using cariporide and amiloride in animal models reveal highly efficacious anti-ischemic benefits of NHE inhibition against myocardial infarction, particularly when administered before the onset of myocardial ischemia 18, 19, 20, 21.